LEADER 02460oam 2200673I 450 001 9910466332403321 005 20200520144314.0 010 $a1-315-25766-1 010 $a1-351-94372-3 024 7 $a10.4324/9781315257662 035 $a(CKB)3710000001081401 035 $a(MiAaPQ)EBC4817060 035 $a(Au-PeEL)EBL4817060 035 $a(CaPaEBR)ebr11356235 035 $a(CaONFJC)MIL997051 035 $a(OCoLC)975222977 035 $a(OCoLC)974711510 035 $a(EXLCZ)993710000001081401 100 $a20180706e20162004 uy 0 101 0 $aeng 135 $aurcnu|||||||| 181 $2rdacontent 182 $2rdamedia 183 $2rdacarrier 200 00$aDisease, diagnosis, and cure on the early modern stage /$fedited by Stephanie Moss and Kaara L. Peterson 210 1$aAbingdon, Oxon :$cRoutledge,$d2016. 215 $a1 online resource (237 pages) 225 1 $aLiterary and Scientific Cultures of Early Modernity 300 $aFirst published 2004 by Ashgate Publishing. 311 $a0-7546-3791-3 311 $a1-351-94373-1 320 $aIncludes bibliographical references and index. 327 $apt. 1. Performance and the practitioner -- pt. 2. Race, nationhood, and discourses of medicine -- pt. 3. Competing discourses. 410 0$aLiterary and scientific cultures of early modernity. 606 $aEnglish drama$yEarly modern and Elizabethan, 1500-1600$xHistory and criticism 606 $aMedicine in literature 606 $aLiterature and medicine$zEngland$xHistory$y16th century 606 $aLiterature and medicine$zEngland$xHistory$y17th century 606 $aEnglish drama$y17th century$xHistory and criticism 606 $aPhysicians in literature 606 $aDiseases in literature 608 $aElectronic books. 615 0$aEnglish drama$xHistory and criticism. 615 0$aMedicine in literature. 615 0$aLiterature and medicine$xHistory 615 0$aLiterature and medicine$xHistory 615 0$aEnglish drama$xHistory and criticism. 615 0$aPhysicians in literature. 615 0$aDiseases in literature. 676 $a822.3093561 701 $aMoss$b Stephanie$0946212 701 $aPeterson$b Kaara L$0946213 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910466332403321 996 $aDisease, diagnosis, and cure on the early modern stage$92137623 997 $aUNINA LEADER 04986nam 2200649Ia 450 001 9910778508203321 005 20230421033158.0 010 $a1-280-20349-8 010 $a9786610203499 010 $a0-309-53794-0 010 $a0-585-03021-9 035 $a(CKB)110986584751114 035 $a(EBL)3376810 035 $a(SSID)ssj0000166523 035 $a(PQKBManifestationID)11164882 035 $a(PQKBTitleCode)TC0000166523 035 $a(PQKBWorkID)10161831 035 $a(PQKB)11463121 035 $a(MiAaPQ)EBC3376810 035 $a(Au-PeEL)EBL3376810 035 $a(CaPaEBR)ebr10060377 035 $a(CaONFJC)MIL20349 035 $a(OCoLC)923266253 035 $a(EXLCZ)99110986584751114 100 $a19920313d1992 uy 0 101 0 $aeng 135 $aur|n|---||||| 181 $ctxt 182 $cc 183 $acr 200 10$aGuidelines for clinical practice$b[electronic resource] $efrom development to use /$fMarilyn J. Field and Kathleen N. Lohr, editors ; Committee on Clinical Practice Guidelines, Division of Health Care Services, Institute of Medicine 210 $aWashington, D.C. $cNational Academy Press$d1992 215 $a1 online resource (440 p.) 300 $aDescription based upon print version of record. 311 $a0-309-04589-4 320 $aIncludes bibliographical references and index. 327 $a""Guidelines for Clinical Practice""; ""Copyright""; ""Acknowledgments""; ""Contents""; ""Guidelines for Clinical Practice""; ""Summary""; ""WHAT ARE PRACTICE GUIDELINES?""; ""WHY ARE POLICY MAKERS INTERESTED IN GUIDELINES?""; ""GENERAL STRENGTHS AND WEAKNESSES OF CURRENT PRACTICE GUIDELINES ACTIVITIES""; ""What Are the Strong Points of Current Efforts?""; ""What Are the Limitations of Current Efforts?""; ""IMPROVING THE DEVELOPMENT OF GUIDELINES""; ""Building a Compelling Case for Recommendations""; ""Procedural and Methodological Issues Needing Particular Attention"" 327 $a""At the Interface Between Development and Use""""Local Adaptation of Guidelines""; ""Inconsistent Guidelines""; ""Formatting and Disseminating Guidelines""; ""Going Further? Defining Cost-Effective and Minimum Levels of Care""; ""Doing More? Guidelines for Informed Patient Decision making""; ""ENSURING THE USE OF GOOD GUIDELINES""; ""Quality Assurance and Improvement""; ""Cost Management""; ""Risk Management and Medical Liability""; ""Information and Decision Support Systems""; ""A CRITICAL NEED: MEANS TO ASSESS THE SOUNDNESS OF GUIDELINES""; ""Assessment Instrument"" 327 $a""Assessment Organization""""RESEARCH AGENDA""; ""FINAL NOTE: GUIDELINES AND HEALTH CARE REFORM""; ""1 Introduction ""; ""PURPOSE OF THE REPORT""; ""WHAT ARE PRACTICE GUIDELINES?""; ""Definitions of Key Terms""; ""Desirable Attributes of Guidelines""; ""Elements of Analysis""; ""State of the Evidence""; ""Inconsistent or Conflicting Guidelines""; ""Types of Guidelines""; ""WHY ARE POLICY MAKERS INTERESTED IN GUIDELINES?""; ""WHO USES GUIDELINES AND FOR WHAT?""; ""BASIC PROPOSITIONS""; ""REPORT ORGANIZATION""; ""SUMMARY""; ""2 Developing Clinical Practice Guidelines "" 327 $a""PLURALISM AND DIVERSITY IN GUIDELINES DEVELOPMENT""""PROFESSIONAL SOCIETIES AND RELATED ENTITIES""; ""How Are Professional Societies Involved?""; ""Why Are Professional Societies Involved?""; ""PUBLIC AGENCIES""; ""U.S. Public Health Service""; ""Food and Drug Administration""; ""National Institutes of Health""; ""Centers for Disease Control""; ""Agency for Health Care Policy and Research""; ""Other Public Agencies""; ""Health Care Financing Administration""; ""U.S. Preventive Services Task Force""; ""Congressional Office of Technology Assessment"" 327 $a""PRIVATE RESEARCH, PAYER, PROVIDER, AND OTHER GROUPS""""COSTS OF GUIDELINES DEVELOPMENT""; ""SUMMARY""; ""3 Implementing Guidelines: Overview and Illustrative Cases ""; ""GUIDELINES AND THE REAL WORLD""; ""CASE STUDIES""; ""Case Study 1: Small Internal Medicine Practice""; ""Case Study 2: Managed Care Organization""; ""Case Study 3: Academic Medical Center Hospital""; ""Case Study 4: Community Hospital""; ""Case Study 5: Nursing Home and Hospice""; ""Case Study 6: Patient""; ""GENERAL ISSUES IN IMPLEMENTATION""; ""Factors Influencing the Effective Use of Guidelines"" 327 $a""Strategies to Encourage Effective Use of Guidelines"" 606 $aMedical care$xStandards$zUnited States 606 $aPhysician services utilization 615 0$aMedical care$xStandards 615 0$aPhysician services utilization. 676 $a362.1/021873 701 $aField$b Marilyn J$g(Marilyn Jane)$01477341 701 $aLohr$b Kathleen N.$f1941-$01506302 712 02$aInstitute of Medicine (U.S.).$bCommittee on Clinical Practice Guidelines. 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910778508203321 996 $aGuidelines for clinical practice$93805767 997 $aUNINA